2m 2m 2m 2m 2m 2m 2m
ARMATA PHARMA (ARMP)
NYSE
$3.39+$0.33 (+10.78%)
Price as of Oct 22, 2026 7:30 PM EDT- $113.8MMarket Cap
- -56.60%1-Year Change
- BiotechnologyIndustry
ARMATA PHARMA (ARMP)
$3.39+$0.33 (+10.78%)
ARMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.06 | ||
Change | -$0.14 (-4.37%) | ||
Open | $3.21 | ||
High | $3.21 | ||
Low | $2.94 | ||
Previous Close | $3.20 | ||
Volume | 93,557 | ||
30-Day Average Volume | 114,360 | ||
1-Week Change | 10.07% | ||
1-Month Change | -28.17% | ||
1-Year Change | -56.60% | ||
3-Year Change | 54.55% | ||
5-Year Change | -1.29% | ||
Fundamentals | |||
Shares Outstanding | 37.2M | ||
Total Assets | $90.0M | ||
Market Cap | $113.8M | ||
Enterprise Value | $449.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $74.1M | ||
Free Cash Flow | -$8.7M | ||
EBIT | $74.1M | ||
EBITDA | $74.7M | ||
Net Working Capital | -$223.0M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/25/2017 | ||
Earnings & Revenue